Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025)
Eton Pharmaceuticals (ETON) reported Amortizatization of Intangibles of $175000.0 for Q4 2025, down 83.16% on a YoY basis from $1.0 million in Q4 2024, and down 7.41% sequentially from $189000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 6 years of Amortizatization of Intangibles data on file, last reported at $175000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 83.16% year-over-year to $175000.0; the trailing twelve-month figure through Dec 2025 stood at $706000.0 (down 36.74% YoY), and the FY2025 full-year result was $696000.0, down 37.24% from the prior year.
- Amortizatization of Intangibles eased to $175000.0 in Q4 2025, from $189000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.0 million in Q4 2024 to a low of $23000.0 in Q2 2024.
- A 5-year average of $113700.0 and a median of $36000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles surged 3748.15% in 2024 and tumbled 83.16% in 2025, its largest moves.
- Tracing ETON's Amortizatization of Intangibles over 5 years: stood at $38000.0 in 2021, then fell by 18.42% to $31000.0 in 2022, then declined by 12.9% to $27000.0 in 2023, then surged by 3748.15% to $1.0 million in 2024, then tumbled by 83.16% to $175000.0 in 2025.
- Business Quant data shows ETON's Amortizatization of Intangibles at $175000.0 in Q4 2025, $189000.0 in Q3 2025, and $48000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.11 Bn | 13.10 Mn | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175,000.00 |
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Sep 30, 2023 | 29,000.00 |